The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology.

Reinholz, Markus; French, Lars E; Berking, Carola; Heppt, Markus V

Reinholz, Markus; French, Lars E; Berking, Carola; Heppt, Markus V.

Reinholz M; Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.
French LE; Department of Dermatology and Allergy, University Hospital, LMU Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.
Berking C; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Heppt MV; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Eur J Dermatol ; 30(6): 757-758, 2020 Dec 01.

Article in English | MEDLINE | ID: covidwho-955344

Subject(s)

COVID-19/etiology; Immunologic Factors/adverse effects; Skin Diseases/drug therapy; COVID-19/epidemiology; Humans; Immunologic Factors/therapeutic use; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases / COVID-19 / Immunologic Factors Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Eur J Dermatol Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Ejd.2020.3775

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google